HISTOLOGICAL CHANGES OF THE PANCREAS IN DIABETES MELLITUS AND PANCREATITIS.

Main Article Content

Zakiryaeva Dilafruz Abdumannobova, Noraliyeva Moxlaroyim Dilmurodovna

Abstract

This paper describes the histological alterations that occur in the pancreas during diabetes mellitus and pancreatitis. In diabetes mellitus, characteristic changes include degeneration and reduction of pancreatic islet cells, hyalinization of blood vessels, and fibrosis of the interstitial tissue. In chronic pancreatitis, inflammatory infiltration, acinar cell atrophy, ductal dilation, and fibrotic replacement of the parenchyma are observed. The comparative analysis of these conditions highlights how both endocrine and exocrine components of the pancreas are affected, leading to impaired metabolic and digestive functions. Understanding these histological features is essential for accurate diagnosis and for developing effective therapeutic approaches.

Downloads

Download data is not yet available.

Article Details

Section

Articles

How to Cite

HISTOLOGICAL CHANGES OF THE PANCREAS IN DIABETES MELLITUS AND PANCREATITIS. (2025). Journal of Multidisciplinary Sciences and Innovations, 4(10), 14-16. https://doi.org/10.55640/

References

1.Bancroft, J. D., & Gamble, M. (2019). Theory and Practice of Histological Techniques. 8th ed. Elsevier Health Sciences.

2.Kumar, V., Abbas, A. K., & Aster, J. C. (2023). Robbins and Cotran Pathologic Basis of Disease. 11th ed. Elsevier.

3.Young, B., O’Dowd, G., & Woodford, P. (2014). Wheater’s Functional Histology: A Text and Colour Atlas. 6th ed. Elsevier.

4.Hall, J. E., & Hall, M. E. (2020). Guyton and Hall Textbook of Medical Physiology. 14th ed. Elsevier.

5.Klöppel, G., & Maillet, B. (2018). Pathology of the pancreas in diabetes mellitus. Pancreas, 47(1), 1–10.

6.Yadav, D., & Lowenfels, A. B. (2013). The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology, 144(6), 1252–1261.

7.Ewald, N., & Hardt, P. D. (2013). Diagnosis and treatment of diabetes mellitus in chronic pancreatitis. World Journal of Gastroenterology, 19(42), 7276–7281.

8.Brancati, F. L., Kao, W. H. L., Folsom, A. R., Watson, R. L., & Szklo, M. (2000). Incident type 2 diabetes mellitus in African American and white adults: The Atherosclerosis Risk in Communities Study. Archives of Internal Medicine, 160(4), 485–492.

9.Apte, M. V., & Wilson, J. S. (2012). Mechanisms of pancreatic fibrosis. Digestive Diseases, 30(4), 423–430.

10.Löhr, J. M., et al. (2017). The histopathology of chronic pancreatitis: Classification, grades, and scoring. Pancreatology, 17(5), 735–742.

11.Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003). β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes, 52(1), 102–110.

12.Whitcomb, D. C. (2020). Genetic risk factors for pancreatic disorders. Gastroenterology, 158(6), 1569–1583.

13.Maléth, J., & Hegyi, P. (2016). Pancreatic epithelial fluid and bicarbonate secretion: Physiological and pathophysiological aspects. Frontiers in Physiology, 7, 63.

14.Wang, Y., & Sun, J. (2019). The role of inflammation and fibrosis in the progression of pancreatitis. Frontiers in Physiology, 10, 1082.

15.Andersen, D. K., & Korc, M. (2017). Diabetes and pancreatic cancer: Pathophysiology and clinical implications. Pancreas, 46(10), 1438–1446.

Similar Articles

You may also start an advanced similarity search for this article.